Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Inventory (2016 - 2025)

China Pharma Holdings' Change in Inventory history spans 16 years, with the latest figure at -$210551.0 for Q4 2025.

  • For Q4 2025, Change in Inventory rose 58.8% year-over-year to -$210551.0; the TTM value through Dec 2025 reached -$589761.0, up 63.3%, while the annual FY2025 figure was -$589761.0, 63.3% up from the prior year.
  • Change in Inventory reached -$210551.0 in Q4 2025 per CPHI's latest filing, down from -$57779.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $552686.0 in Q1 2023 to a low of -$679042.0 in Q2 2021.
  • Average Change in Inventory over 5 years is -$194030.0, with a median of -$210972.0 recorded in 2021.
  • Peak YoY movement for Change in Inventory: tumbled 6335.2% in 2021, then skyrocketed 311.81% in 2022.
  • A 5-year view of Change in Inventory shows it stood at -$255815.0 in 2021, then rose by 24.59% to -$192902.0 in 2022, then crashed by 34.09% to -$258659.0 in 2023, then crashed by 97.56% to -$510996.0 in 2024, then skyrocketed by 58.8% to -$210551.0 in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Change in Inventory are -$210551.0 (Q4 2025), -$57779.0 (Q3 2025), and -$164804.0 (Q2 2025).